26-Oct-2026 09:04:01
BIOCON : SECURES MARKET ENTRY RIGHTS FOR YESINTEK BIOSIMILAR IN 9 ADDITIONAL GLOBAL MARKETS
• License Agreement: Signed agreement with Janssen Sciences Ireland for commercialization of Yesintek, a proposed biosimilar to Stelara (Ustekinumab) • New Mar…